Skip to the answer

Levoketoconazole Uses, Dosage, Side Effects and Interactions

Brand name
Recorlev

Recorlev was the first levoketoconazole product the FDA approved, in December 2021. No generic is listed as tablets.

First generic of Recorlev: our estimate, 2034 to 2035

Levoketoconazole is a cortisol synthesis inhibitor used to treat Cushing's syndrome — a condition where the body makes too much cortisol — in adults who cannot have surgery or whose surgery did not work.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About LevoketoconazoleType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Levoketoconazole in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Levoketoconazole (Recorlev) is a specialist medicine for adults with Cushing's syndrome when surgery is not an option or has not worked, lowering the body's excess cortisol by blocking enzymes needed to make it; a relative of the antifungal ketoconazole, it has been on the U.S. market since about 2021 and is not available as a generic. Nausea, tiredness and headache are the side effects people most often notice, which is one reason the dose is raised slowly. It carries a boxed warning for serious liver injury and QT prolongation (a heart rhythm change that can turn dangerous), so stop it and call your prescriber right away for yellow skin or eyes, dark urine or unusual tiredness.

Key Takeaways From the HelloPharmacist Team

  • Take it twice a day, with or without food, and expect slow dose increases every few weeks guided by 24-hour urine cortisol tests.
  • Expect liver blood tests and an ECG (heart tracing) before starting and regularly after, plus potassium and magnesium checks.
  • Give every pharmacy and prescriber your full medicine list, since many common drugs, including some antibiotics and acid reducers, clash with it.
  • Report extreme tiredness, vomiting or dizziness right away, since these can mean your cortisol has dropped too low.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Levoketoconazole.

Recorlev carries a serious warning for two major risks: liver damage and abnormal heart rhythms.

Liver damage: Severe liver injury — including cases requiring liver transplant or resulting in death — has been reported with oral ketoconazole (the related compound) and with Recorlev itself. Some patients had no known liver disease before starting. Recorlev must not be used in people who already have significant liver disease. Liver enzyme blood tests are required before starting and regularly throughout treatment. Stop taking Recorlev and seek medical care right away if you develop yellowing skin or eyes, dark urine, or severe tiredness.

Heart rhythm changes (QT prolongation): Recorlev can prolong the QT interval — an electrical measurement of your heart's rhythm — in a dose-related way. This can lead to a life-threatening irregular heartbeat called torsades de pointes. Recorlev cannot be used with other medications that also prolong QT, or in people who already have a prolonged QT interval or a personal or family history of certain heart rhythm disorders. An ECG and electrolyte blood tests are required before and during treatment.

Read the full warning on DailyMed →

Levoketoconazole by the Numbers

Strengths
1
in one form
Makers and packagers
1
Earliest FDA record
2021
Rank by Medicaid prescriptions
#1,478 of 1,682 drugs
More prescriptions than 12% of the 1,682 drugs we measure
316 prescriptions, Q1–Q4 2025

Patient Information Guide for Levoketoconazole

What It’s Used For

Levoketoconazole is approved for a specific hormonal condition in adults.

  • Recorlev (levoketoconazole) tablets are indicated for the treatment of Cushing's syndrome in adults with endogenous hypercortisolemia (the body making too much cortisol on its own) — specifically when surgery is not an option or has not cured the condition.
  • Recorlev is not approved to treat fungal infections; its safety and effectiveness for that purpose have not been established.

How It Works

Levoketoconazole works by blocking several key enzymes — CYP11B1, CYP11A1, and CYP17A1 — that are essential steps in the body's process of making cortisol. By blocking these enzymes, it reduces the amount of cortisol the body produces. Because these same enzymes are involved in testosterone production, levoketoconazole can also lower testosterone levels in both men and women.

Drug Class

Drug Class

  • Cortisol Synthesis Inhibitor
  • Azole Antifungal
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Cortisol Synthesis Inhibitor
  • Azole Antifungal

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Cytochrome P450 2B6 Inhibitors
  • Cytochrome P450 3A4 Inhibitors
  • Cytochrome P450 17A1 Inhibitors
  • P-Glycoprotein Inhibitors
  • Organic Cation Transporter 2 Inhibitors
  • Cytochrome P450 2C8 Inhibitors
  • Multidrug and Toxin Extrusion Transporter 1 Inhibitors
  • Cytochrome P450 11B1 Inhibitors

and 2 more

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Levoketoconazole in the FDA’s index.

From our Patient Information GuideLevoketoconazole works by blocking several key enzymes — CYP11B1, CYP11A1, and CYP17A1 — that are essential steps in the body's process of making cortisol. By blocking these enzymes, it reduces the amount of cortisol the body produces. Read How Levoketoconazole Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Azoles

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Anticorticosteroids
  • Imidazole and triazole derivatives
  • Imidazole derivatives

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Recorlev tablets are taken by mouth twice daily, with or without food — food does not meaningfully change how much drug is absorbed. Your prescriber will start you at a low dose and increase it gradually every 2–3 weeks, guided by urine cortisol measurements and how well you tolerate the medication.

Once your dose is stable, cortisol levels are monitored at least every 1–2 months.

  • Take Recorlev at roughly the same times each day as directed by your prescriber
  • If antacids are needed, take them at least 2 hours after your Recorlev dose to avoid reducing absorption
  • Do not stop or adjust your dose without talking to your doctor first — if cortisol drops too low, your dose may need to be reduced or paused

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

High cortisol from Cushing's syndrome

Adults · Starting dose Starting dose 150 mg twice a day
  • 150 mg orally twice daily, with or without food
Adults · Increasing the dose Highest dose 600 mg twice a day
  • Titrate the dosage by 150 mg daily, no more frequently than every 2-3 weeks based on 24-hour urine free cortisol levels and patient tolerability

Good to know

May be reduced to 150 mg once daily if needed for tolerability

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects reported with Recorlev include:

Common side effects

  • Nausea or vomiting
  • Fatigue
  • Headache
  • Low potassium levels (hypokalemia)
  • High blood pressure
  • Abnormal uterine bleeding
  • Skin redness or flushing (erythema)
  • Abdominal pain or upset stomach
  • Dizziness and diarrhea
  • Joint or muscle aches

When to get medical help

  • Signs of liver problems: yellowing of the skin or eyes, dark urine, severe nausea, unusual tiredness, or upper-right abdominal pain — seek medical help immediately
  • Signs of abnormal heart rhythm (QT prolongation): pounding or irregular heartbeat, dizziness, or fainting
  • Signs of low cortisol (adrenal insufficiency): extreme fatigue, nausea, vomiting, dizziness, low blood pressure, or low blood sugar — contact your doctor right away
  • Severe allergic reaction: hives, difficulty breathing, or swelling of the face or throat (anaphylaxis has been reported with ketoconazole)
  • Signs of low testosterone: breast enlargement in men, sexual dysfunction, or mood changes — tell your doctor

More serious reactions to watch for include liver injury (yellowing skin or eyes, dark urine, fatigue), dangerous heart rhythm changes (pounding or irregular heartbeat, fainting), and signs of too-low cortisol (extreme tiredness, nausea, dizziness, low blood pressure). Contact your doctor right away if any of these occur.

Warnings and Precautions

  • Liver damage: This is the most critical risk. Severe liver injury — including fatal cases and cases requiring liver transplant — has been reported. Liver tests must be done before starting Recorlev and monitored frequently throughout treatment. Stop Recorlev and seek immediate care if you develop jaundice (yellowing of skin or eyes), dark urine, or severe fatigue.
  • Heart rhythm changes (QT prolongation): Recorlev can prolong the QT interval in a dose-dependent way, potentially causing life-threatening irregular heartbeats. An ECG is required before and during treatment. Low potassium and magnesium levels increase this risk and must be corrected before starting.
  • Low cortisol (hypocortisolism / adrenal insufficiency): Because Recorlev lowers cortisol, it can sometimes lower it too much, causing adrenal insufficiency — a potentially life-threatening condition. Symptoms include nausea, vomiting, dizziness, fatigue, and low blood pressure. Monitor cortisol levels regularly and report symptoms promptly.
  • Decreased testosterone: Recorlev may lower testosterone in men and women. Men may experience breast enlargement, impotence, or reduced sperm count. Women may experience decreased libido or mood changes. Tell your doctor if these occur.
  • Hypersensitivity reactions: Allergic reactions including anaphylaxis (severe whole-body allergic reaction) have been reported with ketoconazole. Seek immediate medical help if you develop difficulty breathing, hives, or swelling of the face or throat.

Interactions

Recorlev is a strong inhibitor of CYP3A4, an important liver enzyme, and also affects drug transporters — meaning it raises blood levels of many other medications. Always share your complete medication list with your doctor and pharmacist before starting Recorlev.

  • QT-prolonging drugs (e.g., clarithromycin, pimozide, quinidine, methadone, dronedarone): contraindicated — combining these raises the risk of dangerous heart rhythm problems
  • Sensitive CYP3A4 substrates (e.g., midazolam, simvastatin, lovastatin, tacrolimus, triazolam): contraindicated or not recommended — Recorlev can dramatically increase their blood levels
  • Atorvastatin: Recorlev greatly increases atorvastatin levels; use the lowest possible dose and watch for muscle side effects
  • Metformin: Recorlev raises metformin levels; monitor blood sugar, kidney function, and vitamin B12
  • Strong CYP3A4 inhibitors (e.g., ritonavir, mifepristone): raise levoketoconazole levels and increase risk of side effects — avoid starting 2 weeks before and during Recorlev treatment
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, efavirenz): reduce Recorlev's effectiveness — avoid starting 2 weeks before and during treatment
  • Antacids: reduce Recorlev absorption — take at least 2 hours after your Recorlev dose
  • Proton pump inhibitors, H2 blockers, and sucralfate: impair Recorlev absorption — avoid use with Recorlev
  • Alcohol: avoid excessive alcohol — it can cause a disulfiram-like reaction (flushing, rash, nausea, swelling, headache) and worsens liver risk

Interactions Listed in the FDA-Approved Label

From the Levoketoconazole prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • QT-prolonging CYP3A4 or CYP3A4 and P-gp substrates For example: bosutinib, cisapride, clarithromycin, methadone, pimozide, quinidine
    What happensIncreases risk of QT prolongation and torsades de pointes.
    What to doConcomitant use is contraindicated.
  • Sensitive CYP3A4 or CYP3A4 and P-gp substrates For example: simvastatin, lovastatin, midazolam, tacrolimus, digoxin
    What happensIncreases plasma concentrations of the substrate and may increase the risk of its adverse reactions.
    What to doConcomitant use is contraindicated or not recommended; refer to the substrate drug's prescribing information.
  • What happensIncreases plasma concentration of atorvastatin and may increase the risk of myopathy and rhabdomyolysis.
    What to doUse the lowest atorvastatin dose possible and monitor for adverse reactions when dosage exceeds 20 mg daily.
  • What happensIncreases plasma concentration of metformin and may increase the risk of its adverse reactions.
    What to doDuring RECORLEV titration, monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed.
  • Strong CYP3A4 inhibitors For example: ritonavir, saquinavir, mifepristone
    What happensMay increase plasma concentrations of levoketoconazole and increase the risk of adverse reactions.
    What to doNot recommended. Avoid use from 2 weeks before and during treatment with RECORLEV.
  • Strong CYP3A4 inducers For example: rifampicin, carbamazepine, phenytoin, efavirenz, mitotane
    What happensMay decrease plasma concentrations of levoketoconazole and reduce the efficacy of RECORLEV.
    What to doNot recommended. Avoid use from 2 weeks before and during treatment with RECORLEV.
  • Gastric acid neutralizers For example: aluminum hydroxide
    What happensImpairs absorption of levoketoconazole from RECORLEV.
    What to doTake gastric acid neutralizers a minimum of 2 hours after dosing with RECORLEV.
  • Gastric acid suppressors (H2-receptor antagonists and proton pump inhibitors)
    What happensImpairs absorption of levoketoconazole from RECORLEV.
    What to doAvoid use with RECORLEV.
  • What happensImpairs absorption of levoketoconazole from RECORLEV.
    What to doAvoid use of sucralfate with RECORLEV.
  • Alcohol
    What happensCases of a disulfiram-like reaction (flushing, rash, peripheral edema, nausea, headache) have been reported with ketoconazole.
    What to doAdvise against excessive alcohol consumption while using RECORLEV.
Read the label’s full interactions text

7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV 7.1 Effect of RECORLEV on Other Drugs Levoketoconazole is a strong CYP3A4 inhibitor, as well as an inhibitor of the drug transporters P-gp, OCT2, and MATE1 in vivo. In vitro, levoketoconazole inhibits CYP2B6 and CYP2C8. Concomitant use of RECORLEV with drugs that are substrates of these CYP enzymes and transporters may increase the risk of adverse reactions of these drugs. Consult the approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE1 prior to initiating therapy with RECORLEV. Table 6 presents drugs affected by RECORLEV that are contraindicated or not recommended for use during RECORLEV use. It also includes the clinical impact and management recommendations for concomitant use of RECORLEV with atorvastatin and metformin. Table 6: Effect of RECORLEV on CYP3A4 and Transporter Substrates a The drugs listed are substrates for CYP3A4 and/or P-gp. Other metabolism and/or transporter pathways may also contribute to elimination of the substrate drug. Consult the approved product labeling for the substrate drug for more information. b Strong CYP3A4 inhibitor. c Based on clinical drug interaction study with levoketoconazole.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Liver disease: Recorlev is contraindicated in people with cirrhosis, active liver disease, poorly controlled chronic liver disease, extensive liver metastases, or prior liver injury from ketoconazole or any azole antifungal that required stopping treatment
  • Heart rhythm conditions: Contraindicated if you have a QTcF interval above 470 msec at baseline, history of torsades de pointes, ventricular tachycardia, ventricular fibrillation, or long QT syndrome — including a first-degree family history
  • Recurrent gallstones: Recorlev is contraindicated in people with recurrent symptomatic cholelithiasis (repeated painful gallstone episodes)
  • Allergy: Do not take Recorlev if you have a known allergy to levoketoconazole, ketoconazole, or any ingredient in Recorlev
  • Pregnancy: Animal studies showed fetal harm at doses similar to human doses. Discuss risks and benefits carefully with your doctor if you are pregnant or could become pregnant
  • Breastfeeding: Do not breastfeed during Recorlev treatment or for at least one day after your final dose — the drug may pass into breast milk and could cause serious harm to a nursing infant
  • Fertility: Recorlev may impair fertility in men and women by lowering testosterone levels
  • Children: Safety and effectiveness in patients under 18 have not been established
  • Older adults: Limited clinical trial data are available for adults 65 and older; use with caution and close monitoring
  • Kidney impairment: Recorlev has not been formally studied in people with kidney impairment

Overdose

If too much Recorlev is taken, treatment is focused on supportive and symptomatic care. If the overdose was recent (within the first hour), activated charcoal may be given to help limit absorption. If you suspect an overdose, contact emergency services or a poison control center immediately.

Half-Life and How Your Body Processes It

After a single oral dose of Recorlev taken on an empty stomach, peak blood levels are reached in about 1.5 to 2 hours. Taking it with a high-fat meal delays the peak by about 2 hours but does not significantly change overall drug exposure, so it can be taken with or without food. The drug is highly protein-bound (about 99%) in the bloodstream. Levoketoconazole is eliminated with a half-life of roughly 3 to 6 hours, and the major route of clearance is through bile into the digestive tract, with a smaller portion excreted in urine. Because it is extensively metabolized by the liver (primarily via CYP3A4), people with liver impairment may clear it more slowly — which is one reason significant liver disease is a contraindication.

Storage

Store RECORLEV at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) (see USP controlled room temperature).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Levoketoconazole: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Levoketoconazole — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly is Recorlev used for — is it the same as a regular antifungal?

Recorlev contains levoketoconazole, which is chemically related to an antifungal called ketoconazole — but Recorlev itself is NOT approved to treat fungal infections. It's specifically approved for adults with Cushing's syndrome, a condition where the body produces too much cortisol. It's only used when surgery isn't an option or didn't fully work. Think of it as a very targeted hormonal treatment, not an antifungal.

How will I know if Recorlev is working?

Your doctor will check your cortisol levels using 24-hour urine collections every few weeks, especially while your dose is being adjusted. If cortisol levels come down into the normal range and your symptoms improve, that's a sign the medication is working. Your dose may be gradually increased until your cortisol is well controlled. If it still isn't controlled at the maximum dose, your doctor will discuss other options with you.

What side effects should I actually worry about versus ones I can manage at home?

Nausea, headache, fatigue, and some stomach upset are common and usually manageable. But there are a few things that need a call to your doctor right away: yellowing of your skin or eyes, dark urine, or unusual tiredness (signs of liver injury); a pounding, racing, or irregular heartbeat or fainting (possible heart rhythm changes); or extreme dizziness, nausea, and weakness that could mean your cortisol has dropped too low. Don't wait — these need prompt attention.

I take a lot of other medications. Is that going to be a problem?

This is really important to address before you start Recorlev. It strongly affects how your body processes many other drugs, which means it can raise or lower their levels in your blood — sometimes to dangerous levels. Certain medications — like some cholesterol drugs, anxiety or sleep medications, antibiotics, and heart rhythm drugs — either cannot be used with Recorlev at all or need careful dose adjustments. Make sure your doctor and pharmacist have a complete, up-to-date list of everything you take, including supplements.

Can I drink alcohol while taking Recorlev?

You should avoid excessive alcohol while on Recorlev. On top of the general liver concerns with this medication, combining it with alcohol has caused a reaction — flushing, rash, swelling, nausea, and headache — similar to what happens when alcohol is mixed with disulfiram (a drug used in alcohol treatment). The symptoms do resolve, but it's best to avoid the situation entirely. Talk to your doctor about what's considered safe for you.

What do I need to know about Recorlev if I'm a woman who could get pregnant?

This is an important conversation to have with your doctor before starting Recorlev. Animal studies showed the drug could harm a developing fetus — including increased pregnancy loss and birth defects at doses similar to those used in humans. If you're pregnant or planning to become pregnant, your doctor needs to carefully weigh the risks and benefits with you. Also, do not breastfeed while taking Recorlev or for at least one full day after your last dose, because the drug can pass into breast milk and could be harmful to a nursing baby.

Is levoketoconazole available over the counter?

No. Levoketoconazole is a prescription medicine: every levoketoconazole product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was levoketoconazole first available?

The earliest FDA record we hold for levoketoconazole is from 2021: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when levoketoconazole was first used.

What is the brand name of levoketoconazole?

Levoketoconazole is the generic name. Its brand name is Recorlev.

What is the generic name of Recorlev?

The generic name of Recorlev is levoketoconazole. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is levoketoconazole?

Levoketoconazole belongs to the drug class Cortisol Synthesis Inhibitor and Azole Antifungal, its established pharmacologic class on the FDA label. The FDA also groups it by how it works: CYP2B6 Enzyme Inhibitor, CYP3A4 Enzyme Inhibitor and Cytochrome P450 17A1 Inhibitor.

What strengths does levoketoconazole come in?

Levoketoconazole is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 150 mg. A listing does not mean every pharmacy stocks every strength.

How much does levoketoconazole cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $404.64 per 150 mg tablet of brand-name Recorlev over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a levoketoconazole shortage?

No. Levoketoconazole is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the levoketoconazole prescribing information (package insert)?

The full FDA-approved prescribing information for levoketoconazole, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Xeris Pharmaceuticals, Inc.'s, revised Mar 10, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Levoketoconazole

Skip the scrolling. Ask in your own words and get an answer from Levoketoconazole’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Levoketoconazole’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Levoketoconazole on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Levoketoconazole Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Levoketoconazole Forms and Strengths (How It Comes)

Levoketoconazole comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Levoketoconazole inactive ingredients by manufacturer.

Tablet

By mouth
Brands Recorlev (the first brand, 2021)
How this form is used
What it may be used for
  • Recorlev is indicated to treat Cushing's syndrome in adults whose body overproduces cortisol, when surgery is not an option or was not curative
  • Recorlev is not approved for the treatment of fungal infections
Important instructions
  • Recorlev tablets are taken by mouth twice daily, with or without food
  • Recorlev dosing is started low and adjusted gradually every 2–3 weeks based on cortisol levels and tolerability — follow your prescriber's schedule exactly
  • If antacids are needed while taking Recorlev, take them at least 2 hours after your Recorlev dose; avoid proton pump inhibitors, H2 blockers, and sucralfate
  • Recorlev requires baseline and ongoing liver tests and ECG monitoring — do not skip these appointments
Available strengths 1 strength
1 FDA-listed product record ⓘ

Levoketoconazole on the U.S. Market: Products, Makers and Brands

How Levoketoconazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 1 Levoketoconazole product record with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Recorlev; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
1
FDA-listed product records ⓘ
2021
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (4) · Unfinished tablet (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Levoketoconazole Is Used (Medicaid Data)

How many Levoketoconazole prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

316
Medicaid prescriptions filled (Q1–Q4 2025)
$8.8M paid by Medicaid, before rebates

How commonly is Levoketoconazole prescribed? Of the 1,682 medications we measure, Levoketoconazole ranks #1,478 by Medicaid prescriptions — more than 12% of them.

Where Levoketoconazole ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Levoketoconazole product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

Other Levoketoconazole products: packs and listings not matched to one strength and form

316 Medicaid prescriptions (Q1–Q4 2025) 100% of Levoketoconazole prescriptions shown $8.8M paid by Medicaid, before rebates ≈ $27,837 per prescription, before rebates

1 of 9 listed NDCs had Medicaid claims.

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 9 listed Levoketoconazole NDCs had Medicaid claims.

Compare Levoketoconazole Products

A representative set of FDA-listed product records for Levoketoconazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Tablet
150 mg Oral Xeris Pharmaceuticals, Inc. NDA View NDC →

Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Levoketoconazole NDCs →

Levoketoconazole Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Levoketoconazole recalls since July 2021.

✅No Levoketoconazole recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

What Medicaid Pays for Levoketoconazole

CMS’s weekly pharmacy survey (NADAC) has no price for Levoketoconazole, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

FormStrengthVersion What Medicaid paid
Tablet · Oral 150 mg Recorlev (brand) $404.64 per tablet NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Levoketoconazole Brand Names

Levoketoconazole has one brand name on record: Recorlev. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Recorlev the first brand, 2021

Who Makes Levoketoconazole: Manufacturers and Labelers

One company lists Levoketoconazole products with the FDA. By number of product records, the largest are Xeris Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Xeris Pharmaceuticals, Inc. 1

Sources for This Levoketoconazole Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Mar 10, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Levoketoconazole.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
1
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Xeris Pharmaceuticals, Inc.
Linked label effective
Mar 10, 2026
Composite sections available
16
Linked SPL Set ID
d4c5fead-bc4a-fb02-e053-2a95a90ae4fc
Linked SPL Document ID
e0c15c64-0299-410c-906d-81633be03375
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Xeris Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →